Ban fast food ads on TV: U.S. doctors Sun,26 Jun 2011 10:43 PM PDT Reuters - NEW YORK (Reuters Health) - Fast food ads on TV are making American youth fatter and should be banned in children's programming, an influential group of doctors said Monday. Full Story1 |
Halozyme keeps options open for ultrafast insulin Sun,26 Jun 2011 02:30 PM PDT Reuters - SAN DIEGO (Reuters) - Halozyme Therapeutics Inc, which specializes in reformulating drug products available only as infusions, expects to have key results this fall from trials of its "ultrafast" insulin formulations. Full Story1 |
"Lean gene" ups risk of heart disease and diabetes Sun,26 Jun 2011 10:07 AM PDT Reuters - LONDON (Reuters) - Being slim may not always lead to a lower risk of heart disease and diabetes, scientists said Sunday after they identified a gene linked both to having a lean body and to a higher risk of metabolic diseases. Full Story1 |
Cream may buy time for snake bite victims Sun,26 Jun 2011 10:04 AM PDT Reuters - HONG KONG, Jun (Reuters) - A chemical compound that is used on heart patients may raise chances of survival for snakebite victims, Australian scientists said on Monday. Full Story1 |
Chronology: Key dates for Roche cancer drug Avastin Sun,26 Jun 2011 09:18 AM PDT Reuters - WASHINGTON (Reuters) - Roche unit Genentech is appealing a U.S. proposal to withdraw breast cancer as an approved use for Avastin, the world's best-selling cancer drug with $6 billion in annual sales. A hearing on the appeal takes place Tuesday and Wednesday. Full Story1 |
France should pay if E.coli warning wrong: British MEP Sun,26 Jun 2011 07:51 AM PDT Reuters - BORDEAUX, France (Reuters) - A British MEP called on France to pay compensation if a British company linked by the French government to an E.coli outbreak in Bordeaux turned out not to be responsible. Full Story1 |
Novo Nordisk says degludec insulin outperforms Sanofi rival Fri,24 Jun 2011 05:00 PM PDT Reuters - COPENHAGEN (Reuters) - Studies showed Novo Nordisk's insulin degludec lowered blood sugar levels with significantly reduced rates of hypoglycaemia when compared with rival Sanofi's Lantus, the Danish firm said on Saturday. Full Story1 |
Amylin study shows insignificant heart rhythm link Fri,24 Jun 2011 04:29 PM PDT Reuters - SAN DIEGO (Reuters) - Analysis of an earlier trial found a "clinically insignificant" link between changes in heart rhythms and use of Bydureon, a long-acting diabetes drug being developed by Amylin Pharmaceuticals, Eli Lilly and Alkermes. Full Story1 |
FDA rejects Pain, Pfizer anti-abuse painkiller Fri,24 Jun 2011 03:46 PM PDT Reuters - BANGALORE (Reuters) - Pfizer Inc and Pain Therapeutics Inc said U.S. health regulators declined to approve their abuse-resistant painkiller Remoxy, less than a week after a similar Pfizer drug was cleared for sale, sending Pain's stock crashing Friday. Full Story1 |
Abbott says blood sugar monitoring devices stolen Fri,24 Jun 2011 02:45 PM PDT Reuters - (Reuters) - Abbott Laboratories said it was working with authorities to retrieve one tractor-trailer shipment of blood glucose monitoring products that was reported stolen on June 19. Full Story1 |
|
email: info@als-alexander.org or interalex2@gmail.com
No comments:
Post a Comment
No adult content please.
Articles accepted having references.
No advertisement accepted.